Apogee Therapeutics
An MSAT Associate Director at Apogee Therapeutics will support late-stage development through launch and commercialization, focusing on delivering robust drug substance manufacturing processes for monoclonal antibodies. The role partners closely with CDMOs and internal development, manufacturing, and supply teams and spans cell line, cell culture, purification, and formulation activities. The position contributes to scale-up from lab to manufacturing, regulatory readiness, and integrated TechOps operations.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2022
Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apogee Therapeutics.
A Look At Apogee Therapeutics (APGE) Valuation After Wider Losses And A New Shelf Registration
2 days ago
Senior Manufacturing Process Scientist
Integrated Resources INC
Engineer/Sr. Engineer
Brinova Fastigheter AB
Director/Senior Director, MSAT
Obsidian Therapeutics
Principal Scientist
GSK plc
MSAT Tech Transfer - Process Engineer (F/H/X)
AbbVie
Principal Scientist Antibody Cell Line Development United States
alnylam